Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Condition: Colorectal Neoplasms Intervention: Drug: Thymalfasin Sponsor: Beijing Friendship Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Research